NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3081% above fair value
$26.56−0.08 (-0.30%)
Close on Nov 13, 2026Market cap $587.50MP/E –Yield 1.96%
NRC Health statistics
92 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 2, 2027 (estimated, before the open)
- Last ex-dividend date
- Dec 29, 2026
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 24.72
- 15.75
Enterprise valuationIndustry
- EV / Sales
- 4.78
- 1.58
- EV / EBIT
- 43.17
- 19.73
- EV / FCF
- 37.23
- 22.45
Share statisticsIndustry
- Shares Change (YoY)
- -3.85%
- 1.02%
- Shares Change (QoQ)
- -4.15%
- 0.00%
- Float
- 11M
- 27M
- Shares Held by Insiders
- 50.4%
- 4.27%
- Shares Held by Institutions
- 48.6%
- 67.7%
Short sellingIndustry
- Short Interest
- 686,809
- –
- Short Interest Change
- -5.34%
- -4.60%
- Short % of Float
- 6.26%
- 5.23%
- Short % of Shares Outstanding
- 3.10%
- 3.31%
- Days to Cover
- 7.10
- 4.22
Stock price statisticsIndustry
- 52-Week High
- $27.60
- –
- 52-Week Low
- $11.73
- –
- 20-Day Moving Average
- $24.00
- –
- 50-Day Moving Average
- $22.13
- –
- 200-Day Moving Average
- $19.41
- –
- Average True Range (14)
- $1.15
- –
- Price Change (1 Week)
- 2.71%
- 1.02%
- Price Change (1 Month)
- 25.8%
- -2.18%
- Price Change (3 Months)
- 22.0%
- -6.06%
- Price Change (6 Months)
- 42.6%
- 0.51%
- Price Change (YTD)
- 41.5%
- -1.13%
- Price Change (1 Year)
- 72.1%
- -4.03%
- Price Change (3 Years)
- -37.3%
- -18.4%
- Price Change (5 Years)
- -44.3%
- -37.5%
- Price Change (10 Years)
- 66.5%
- 86.3%
- Average Volume (10 Days)
- 133,099
- –
- Average Volume (20 Days)
- 116,884
- –
- Average Volume (90 Days)
- 112,984
- –
- Relative Volume
- 1.04
- 0.69
- Relative Strength Index (14)
- 67.5
- 45.8
- Volatility (1 Year)
- 57.8%
- 62.9%
- Beta (5 Years)
- 0.51
- 0.83
MarginsIndustry
- Pretax Margin
- 7.31%
- 2.70%
- EBITDA Margin
- 17.0%
- 3.79%
- FCF Margin
- 12.8%
- 5.92%
Returns on capitalIndustry
- Return on Invested Capital (ROIC)
- 10.9%
- 5.25%
- Return on Capital Employed (ROCE)
- 16.3%
- 3.71%
Financial positionIndustry
- Current Ratio
- 0.64
- 1.36
- Quick Ratio
- 0.45
- 0.75
- Debt / EBITDA
- 4.22
- 2.28
- Debt / FCF
- 5.58
- 4.31
- Net Debt / EBITDA
- 4.07
- 1.90
- Interest Coverage
- 2.91
- -0.21
GrowthIndustry
- Revenue Growth (YoY)
- 3.37%
- 5.34%
- FCF Growth (YoY)
- 58.7%
- -6.06%
- Revenue Growth (3Y CAGR)
- -3.22%
- 5.14%
- Revenue Growth (5Y CAGR)
- 0.61%
- 7.65%
- EPS Growth (3Y CAGR)
- 240.2%
- 4.38%
- EPS Growth (5Y CAGR)
- 103.0%
- 9.57%
EfficiencyIndustry
- Asset Turnover
- 1.05
- 0.82
- Revenue Per Employee
- $402.77K
- $215.67K
- Employee Count
- 357
- 99
- WACC
- 7.03%
- 8.43%
Income statement (TTM)Industry
- Pretax Income
- $10.51M
- -$31.25K
Balance sheetIndustry
- Net Cash (Debt)
- -$99.27M
- $15.49K
- Net Cash Per Share
- -$4.49
- $0.00
- Equity (Book Value)
- -$9.12M
- $10.55M
- Book Value Per Share
- -$0.41
- $0.73
- Tangible Book Value
- -$77.32M
- $13.82K
- Working Capital
- -$15.14M
- $4.37M
Cash flow (TTM)Industry
- Capital Expenditures
- -$5.32M
- -$6.55M
- FCF Per Share
- $0.83
- $0.47
Dividends and yieldsIndustry
- FCF Yield
- 3.14%
- 2.69%
- Dividend Yield
- 1.96%
- 1.56%
- Buyback Yield
- 4.35%
- 2.36%
- Shareholder Yield
- 6.31%
- 2.63%
- Dividend Per Share
- $0.52
- $0.52
- Dividend Growth (YoY)
- 8.33%
- 7.42%
- Years of Dividend Growth
- 1
- 1
- FCF Payout Ratio
- 73.0%
- 35.6%
Taxes and interestIndustry
- Interest Expense
- $5.48M
- $476.57K
- Income Tax
- $4.07M
- $1.16M
- Effective Tax Rate
- 38.7%
- 24.1%
Scores and fair valueIndustry
- Altman Z-Score
- 3.42
- 2.96
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NRC | S&P 500 | Difference | NRC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +31.7% | -3.0% | +34.7 pts | ||
| 3 months | +25.6% | -2.8% | +28.4 pts | ||
| Year to date | +45.1% | +11.5% | +33.6 pts | ||
| 1 year | +76.7% | +13.5% | +63.3 pts | ||
| 3 years | -31.0% | +77.7% | −108.7 pts | -11.6% | +21.1% |
| 5 years | -36.2% | +72.6% | −108.9 pts | -8.6% | +11.5% |
| 10 years | +105.5% | +308.2% | −202.7 pts | +7.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M NRC shares were sold short on Oct 30, 2026, down 5.3% from the previous report, or 6.26% of the shares available to trade. At recent volumes it would take 7.1 days to buy them back. Over the last 20 sessions, 44.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 686,809 | -5.3% | 96,692 | 7.1 |
| Oct 15, 2026 | 725,577 | +5.8% | 89,898 | 8.1 |
| Sep 30, 2026 | 685,621 | +0.0% | 137,593 | 5.0 |
| Sep 15, 2026 | 685,377 | +7.6% | 115,624 | 5.9 |
| Aug 31, 2026 | 636,681 | +14.9% | 114,993 | 5.5 |
| Aug 14, 2026 | 554,321 | +7.6% | 125,330 | 4.4 |
| Jul 31, 2026 | 515,170 | -1.1% | 95,968 | 5.4 |
| Jul 15, 2026 | 520,821 | +11.1% | 84,522 | 6.2 |
| Jun 30, 2026 | 468,676 | +12.2% | 135,267 | 3.5 |
| Jun 15, 2026 | 417,850 | -10.4% | 203,028 | 2.1 |
| May 29, 2026 | 466,579 | +2.2% | 101,740 | 4.6 |
| May 15, 2026 | 456,739 | +3.6% | 121,473 | 3.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?